Results 161 to 170 of about 1,091,780 (307)
How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley +1 more source
TRENDS AND CHALLENGES OF ROMANIAN BROKERAGE INSURANCE MARKET [PDF]
The distribution of insurance products represents a key aspect regarding theattainment of positive results by insurers. Insurance brokers represent one of the majordistribution channels in some national markets, including Romania.
Adina Elena Danuletiu +1 more
core
Regulators use expedited approval pathways to speed market approval and patient access to promising new drugs. However, there is uncertainty about whether these pathways are successful in approving drugs with significant therapeutic advantages. This systematic review aims to examine the safety, effectiveness and cost‐effectiveness of drugs approved via
Ashleigh Hooimeyer +4 more
wiley +1 more source
Current status and trends of global insurance market
The article analyzes the current status and trends in the global insurance market, quantitative and regional structure of its participants; identifies the countries leading the global insurance market and explaines their position on the world market. The
Serhiy Bunin
doaj
Abstract Aim The French authorities mandated the use of secure prescriptions for pregabalin on May 2021. This study aimed to evaluate the impact of this measure on pregabalin use and misuse in Nouvelle‐Aquitaine, a southwestern French region with around six million inhabitants.
Maika Munech‐Herran +5 more
wiley +1 more source
Asymmetric Information With Multiple Risks: The Case of the Chilean Private Health Insurance Market. [PDF]
de la Mata D +3 more
europepmc +1 more source
Social insurance and the completion of the internal market [PDF]
With the completion of the internal market in the EU pressures may arise to diminish social insurance budgets. In a two-country model with an (imperfectly) integrated consumer goods market it is shown that competitive member states use the social ...
Lejour, A.M.
core +1 more source
Abstract Health care is shifting towards a digital‐guided system, integrating digital diagnostics, biomarkers and therapeutics in many care pathways. However, despite rapid technological advancement and preliminary adoption accelerated by the COVID‐19 pandemic, a significant implementation gap persists. This narrative review explores the causes of this
Mees H. P. Stoop +3 more
wiley +1 more source
Consumer behavior and insurer plan offering with expanded premium subsidy in U. S. individual health insurance market. [PDF]
Lei Y.
europepmc +1 more source
Health Insurance as a Two-Part Pricing Contract [PDF]
Monopolies appear throughout health care markets, as a result of patents, limits to the extent of the market, or the presence of unique inputs and skills. In the health care industry, however, the deadweight costs of monopoly may be small or even absent.
Darius Lakdawalla, Neeraj Sood
core

